BJMO - 12, issue 3, february 2018
S. Aspeslagh MD, PhD
BJMO - 12, issue 3, february 2018
E. Seront MD, PhD
Multiple immune checkpoint inhibitors (ICIs) are currently available for the treatment of bladder cancer. The question raised by Dr Seront in his lecture was: “which agent should be used for which patient?”
Read moreBJMO - 12, issue 3, february 2018
L. Dirix MD, PhD
It has become a yearly tradition during the annual BSMO meeting to have a presentation by Dr Luc Dirix discussing the top stories in oncology over the past year. The 2018 edition was no exception.
Read more
Top
